Mentometer urologi

2. Hematuria 3. Skeletal pain 4. Renal insufficiency Skeletal p
tral zone: .
Transition zon. .
A 58-year old male comes into your office for a physical examination to qualify for a life insurance policy. On digital rectal examination, he is found to have a 1.5cm non-tender, firm nodule at the right apex of his prostate. His PSA was checked 7 months ago and was found to be 1.9ng/ml. What is the 2. Refer to urologist 3. Urinary dipstick and Which of the following alternatives are not first choice therapy in moderately differentiated local prostate 2. ”Watchful waiting” 3. TUR P 4. Radikal atchful w
ikal prosta. B
Extern strålbe. .
2. Pelvic lgll then spine 3. Inguinal lgll then ikula sem
Pelvic lg
Inguinal lgll .
A 68-year old male diagnosed with localized prostate cancer (Gleason 6, PSA 4.3 ng/ml, normal prostate exam) is trying to decide between therapy with external beam radiotherapy (XRT), brachytherapy (placement of radioactive seeds in the prostate), or radical prostatectomy. What is a major side effect of 2. ED 3. Loss of Libido 4. Peyronies disease strict. .
A 76-year old male was lost to follow-up after his radical prostatectomy for prostate cancer 10 years ago and now presents to the emergency department with new hip pain. Plain films show osteoblastic metastases to his pelvis, femurs and spine. PSA level is 324 ng/ml. His neurologic examination is normal. What is the most appropriate form of therapy for this patient? ical prosta.
onal thera
External radio.
All the following are riskfactors for ED tand yper
Pelvic surger
All of the following are side-effects of lue vision
Sudden death w
Which of the following groups of urological lpha 1 block
Phosphodiester. .
A 58-year old male presents with severe lower urinary tract symptoms (weak stream, straining to empty, nocturia x 4) which has been unresponsive to maximal medical therapy (an alpha-blocker with 5-alpha reductase inhibitor). Urodynamics have confirmed bladder outlet obstruction due to an enlarged prostate. Al of the following are potential surgical therapies for BPH, EXCEPT: NA (radio wa
Open radical p. .M
Open adenom
Which of the following pharmacotherapy betters lfa blockare.
2. Mindre än 4 3. Mindre än 1 4. Omätbart indre än 10
indre än 4
indre än 1
Your healthy 63-year old patient, Mr. Gore, completes an International Prostate Symptom Score (IPSS) questionnaire which documents his moderate urinary symptoms (weak urinary stream, urgency and nocturia x 4). His urinalysis is normal, his post-void residual is low (15cc), and his prostate is mildly enlarged on examination. What is the next step in the management of urinary symptoms? lphablock. . lphareduc. .
eferal to uro.eferal to uro.eferal to uro.
A 73-year old male with a history of moderate lower urinary symptoms (LUTS) is unable to urinate after undergoing a laparoscopic cholecystectomy (gallbladder excision). All of the following are potential triggers for his urinary retention, EXCEPT: 3. Diphenhydramin for sleep 4. Rinexin (alpha stimulator) Prostatitis
ravenous o enh
2. Emptying in portions 3. Straining micturition 4. Incomplete emptying eak stream
ptying in po. .
Straining m
Incomplete emp. . Fr


Dutton and swindells 'the stag and hound'

Dutton and Swindells 'The Stag and Hound' Finding Us Free E-Bulletins Contact Dutton and Swindells 'The Stag and Hound' Pieces of 20 January - 26 March 2011 Pieces of Private view and book launch 15 February, 6-8pm Eight Events Objects, texts, animations and sound works which form Visionaries part of the Institute of Beasts project, that willevolve in the spac

Safety Data Sheet Tetracycline 1. PRODUCT AND COMPANY IDENTIFICATION Product Name: Tetracycline Synonyms/Generic Names: 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12aoctahydro-3,6,10,12,12a- pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide hydrochloride SDS Number: 753.00 Product Use: For Educational Use Only Manufacturer: Columbus Chemical Industries, Inc.

Copyright © 2010 Find Medical Article